The latest research from Fore Pharma, Global Osteoporosis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Osteoporosis pipeline products, Osteoporosis epidemiology, Osteoporosis market valuations and forecast, Osteoporosis products and competitive landscape.
The research focuses on key countries such as the US, Germany, France, Italy, Spain, UK, and Japan. This report is classified into eleven sections – Osteoporosis overview including etiology, pathophysiology, and diagnosis, Osteoporosis treatment options, Osteoporosis pipeline products, Osteoporosis market analysis globally and by each country. The market analysis comprises of Osteoporosis epidemiology, key products marketed for Osteoporosis, market valuations and forecast, products sales and market shares.
Research Scope: - Osteoporosis Pipeline: Find out the products in clinical trials for the treatment of Osteoporosis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Osteoporosis Epidemiology: Find out the number of patients diagnosed (prevalence) with Osteoporosis in the US, Germany, France, Italy, Spain, UK, and Japan - Osteoporosis Products: Identify key products marketed and prescribed for Osteoporosis in the US, Germany, France, Italy, Spain, UK, and Japan, including trade name, molecule name, and company - Osteoporosis Product Sales: Find out the sales revenues of Osteoporosis products, both branded and generics, in the US, Germany, France, Italy, Spain, UK, and Japan - Osteoporosis Market Valuations: Find out the market size for Osteoporosis products in 2015 for the markets: US, Germany, France, Italy, Spain, UK, and Japan. Find out how the market advanced from 2010 and forecast to 2020 - Osteoporosis Products Market Share: Find out the market shares for key Osteoporosis products in the US, Germany, France, Italy, Spain, UK, and Japan
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Osteoporosis market analysis and sales trends - Track competitor drugs sales and market share in Global Osteoporosis market - Track competitive developments in Osteoporosis market and present key issues and learnings - Synthesize insights for Osteoporosis market and products to drive business performance - Answer key business questions about the Osteoporosis market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Osteoporosis products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
192 pages •
By Global Industry Analysts
• Apr 2021
- Global Chronic Kidney Disease (CKD) Drugs Market to Reach $15.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Chronic Kidney Disease (CKD) Drugs estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 1.9% over...
Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028 Home Infusion Therapy Market Growth & Trends The global home infusion therapy market...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate (CAGR) of -6.27%. The decline...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
The Europe electronic skin patches market is registered to project a CAGR of 16.41%, during the forecast years of 2021 to 2028. The region’s key market growth drivers are, the surging number of research and development activities, the rising healthcare expenditure, and the increasing geriatric population.
The Europe 3D Ultrasound Market would witness market growth of 8% CAGR during the forecast period (2020-2026). The driving elements for the development of the ultrasound devices market incorporate the government and private subsidizing for R&D in ultrasound imaging, an expanding number of medical care suppliers, development in technology,...
The Europe Urinary Drainage Bags Market would witness market growth of 5.4% CAGR during the forecast period (2020-2026). The swift increase in the geriatric population is the main factor that is responsible for the growing demand for urinary drainage bags. Numerous changes occur in the urinary system of an old person such as weakening...
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
In Vitro Diagnostic Reagent
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.